We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Plasma Citrulline Level in Relation to Absorptive Surface

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00286039
First Posted: February 2, 2006
Last Update Posted: September 30, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University Hospital, Ghent
  Purpose

Correlation between determination of citrulline in plasma or dried blood

Reference ranges for healthy children and babies

Longitudinal follow-up of citrulline in preterm babies


Condition Intervention
Intestinal "Failure" Procedure: Blood sampling

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Plasma Citrulline Level in Relation to Absorptive Surface

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Correlation between determination of citrulline in plasma or dried blood [ Time Frame: Untill end of study ]
  • Reference ranges for healthy children and babies [ Time Frame: Until end of study ]
  • Longitudinal follow-up of citrulline in preterm babies [ Time Frame: Untill end of study ]

Estimated Enrollment: 200
Study Start Date: August 2005
Study Completion Date: September 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: Blood sampling
    Blood sampling is used.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 0-18 years
  • preterm babies up to 1.500g
  • preterm babies over 1.500g

Exclusion Criteria:

  • gastro-intestinal problems (except for the preterm babies)
  • congenital metabolic disorders
  • dysfunction of the liver or kidneys
  • congenital defects
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00286039


Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Eddy Robberecht, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
Responsible Party: University Hospital, Ghent
ClinicalTrials.gov Identifier: NCT00286039     History of Changes
Other Study ID Numbers: 2005/163
First Submitted: February 1, 2006
First Posted: February 2, 2006
Last Update Posted: September 30, 2011
Last Verified: September 2011